What did @paulbakhtiar actually say?
The claim is that three peptides, GHK-Cu, BPC-157, and TB-500, form a skin health protocol. GHK-Cu allegedly helps with "boosting up your collagen intake" and fills in "the collagen deficiency in fine lines." BPC-157 "will help the collagen absorption." TB-500 "will help to increase your own natural stem cell production." These are specific mechanistic claims, not vague wellness suggestions, and they deserve specific scrutiny.
To be fair, the creator hedged in the caption with "may support" language. But in the actual video transcript, those qualifiers disappear. The spoken claims are stated as facts: it "will go in," it "will help." That gap between written disclaimer and spoken confidence matters when people are making decisions about injecting peptides.
Does the science back this up?
Partially, but the framing is sloppy in ways that could mislead someone. GHK-Cu has the strongest skin-related evidence of the three. The collagen connection for TB-500 and BPC-157 is real but much more indirect than presented here.
GHK-Cu (copper tripeptide-1) has genuine research behind it. Pickart and Margolina (2018, Cosmetics) reviewed decades of evidence showing GHK-Cu stimulates collagen synthesis and may activate tissue remodeling genes. Studies by Finkley et al. have shown topical application can increase skin thickness and reduce fine lines in small trials. The mechanism involves fibroblast activation, not simply "filling in" collagen like spackle, which is how the video frames it.
BPC-157 has shown pro-angiogenic and tendon-repair properties in animal models. Sikiric et al. (2018, Current Pharmaceutical Design) documented its effects on growth factor signaling, including some collagen-adjacent pathways. But "collagen absorption" is not a recognized mechanism for BPC-157, and no human skin trials exist.
TB-500 (Thymosin Beta-4) promotes actin regulation and wound healing. Goldstein and Kleinman (2015, Annals of the New York Academy of Sciences) confirmed its role in tissue repair. Calling it a "natural stem cell production" booster is an oversimplification that conflates wound-healing mechanisms with stem cell biology.
What did they get wrong (or right)?
The GHK-Cu collagen claim is directionally correct but mechanistically muddled. It does not "fill in the collagen deficiency" like a topical filler. It signals fibroblasts to produce more collagen. That is a meaningful distinction because it affects expectations and timelines.
The phrase "collagen absorption" for BPC-157 is where things go sideways. There is no established mechanism by which BPC-157 improves collagen absorption as a primary skin action. Its tissue-repair effects are real, but calling it a collagen absorption agent for skin is not supported by current literature. That is a misleading framing.
The TB-500 stem cell claim is the loosest of the three. Thymosin Beta-4 supports progenitor cell migration in wound contexts, but describing this as increasing "your own natural stem cell production" implies a far broader regenerative effect than the evidence supports. It sounds compelling. It is also an overreach.
Credit where it is due: the creator is not making disease treatment claims here, and sticking to these three peptides rather than stacking six compounds is relatively restrained compared to other content in this space.
What should you actually know?
None of these peptides are FDA-approved for cosmetic or skin rejuvenation use. GHK-Cu is used in some topical cosmetic formulations, but injectable GHK-Cu for skin health exists in a regulatory gray zone. BPC-157 and TB-500 are research chemicals in the United States, not approved drugs, and their use in humans is off-label and largely unsupported by clinical trials.
If you are considering any of these compounds, that conversation belongs with a licensed clinician who can review your health history, not an Instagram video. Compounded peptides vary significantly in purity and concentration across providers, and quality control is not guaranteed.
The skin benefits described, particularly for BPC-157 and TB-500, are extrapolated from animal studies and wound-healing contexts. That is not the same as evidence they will improve your complexion. The gap between "this compound affects collagen pathways in rats" and "this will smooth your fine lines" is larger than a 60-second video can honestly cover.